3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
5
Classical hematology
4
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Conditions
Multiple Myeloma
323
Lymphoma
86
Leukemia
63
Precursor Cell Lymphoblastic Leukemia-Lymphoma
62
Lymphoma, Non-Hodgkin
62
Hodgkin Disease
60
Leukemia, Lymphocytic, Chronic, B-Cell
58
Neoplasms, Plasma Cell
56
Leukemia, Myeloid, Acute
50
Lymphoma, Mantle-Cell
47
Myelodysplastic Syndromes
44
Lymphoma, Follicular
44
Myeloproliferative Disorders
42
Lymphoma, Large B-Cell, Diffuse
42
Lymphoma, B-Cell, Marginal Zone
40
Burkitt Lymphoma
40
Neoplasms
39
Lymphoma, Large-Cell, Immunoblastic
38
Primary Myelofibrosis
37
Lymphoma, T-Cell, Cutaneous
35
Sezary Syndrome
33
Mycosis Fungoides
33
Leukemia, Myeloid, Chronic-Phase
33
Leukemia, Myeloid, Accelerated Phase
33
Congenital Abnormalities
31
Hematologic Neoplasms
30
Blast Crisis
30
Leukemia, Hairy Cell
29
Breast Neoplasms
29
Leukemia, Myelomonocytic, Chronic
27
Interventions
enoxaparin sodium
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Enoxaparin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Pulmonary Embolism
×
Plasma cell
×
Clear all
NCT07270263
2025-12-26
HEM-DOAC
Medical University of Gdansk
Phase NA
Recruiting
100 enrolled